# Eli Lilly invests $400M in Indianapolis manufacturing facilities

Eli Lilly announced a $400 million capital investment in its manufacturing facilities at the Lilly Technology Center campus in Indianapolis, Indiana, to increase capacity for insulin and other diabetes medicines and add about 100 highly skilled jobs.

- Type: Investment
- Announced: 2019-11-20
- Where: Indianapolis, Indiana, United States
- Value: $400.0M
- Jobs: 100
- Status: announced
- Products: insulin, diabetes medicines, syringe filling, device assembly
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly and Company](https://endata.com/companies/16522.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/lilly-announces-400-million-capital-investment-in-manufacturing-facilities-in-indianapolis-300961247.html), 2019-11-20: "Lilly today announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.